These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 9822506)

  • 1. Quantitative immunophenotypic characterization, cryopreservation, and enrichment of second- and third-trimester human fetal cord blood hematopoietic stem cells (progenitor cells).
    Surbek DV; Holzgreve W; Jansen W; Heim D; Garritsen H; Nissen C; Wodnar-Filipowicz A
    Am J Obstet Gynecol; 1998 Nov; 179(5):1228-33. PubMed ID: 9822506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The activity in ex vivo expansion of cord blood myeloid progenitor cells before and after cryopreservation.
    Wang SY; Hsu ML; Huang MZ; Hsu HC; Tzeng CH; Hung JH; Ho CK
    Acta Haematol; 2001; 105(1):38-44. PubMed ID: 11340252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-surface antigen expression in early and term gestation fetal hematopoietic progenitor cells.
    Opie TM; Shields LE; Andrews RG
    Stem Cells; 1998; 16(5):343-8. PubMed ID: 9766814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of CD38 antigen on CD34+CD38+ cells during short-term culture.
    von Laer D; Corovic A; Vogt B; Fehse B; Roscher S; Rimek A; Baum C; Ostertag W
    Leukemia; 2000 May; 14(5):947-8. PubMed ID: 10803533
    [No Abstract]   [Full Text] [Related]  

  • 5. Myeloid-lymphoid initiating cells (ML-IC) are highly enriched in the rhodamine-c-kit(+)CD33(-)CD38(-) fraction of umbilical cord CD34(+) cells.
    Liu H; Verfaillie CM
    Exp Hematol; 2002 Jun; 30(6):582-9. PubMed ID: 12063025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Normal development of human fetal hematopoiesis between eight and seventeen weeks' gestation.
    Pahal GS; Jauniaux E; Kinnon C; Thrasher AJ; Rodeck CH
    Am J Obstet Gynecol; 2000 Oct; 183(4):1029-34. PubMed ID: 11035358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Candidate hematopoietic stem cells from fetal tissues, umbilical cord blood vs. adult bone marrow and mobilized peripheral blood.
    Huang S; Law P; Young D; Ho AD
    Exp Hematol; 1998 Nov; 26(12):1162-71. PubMed ID: 9808056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiparameter-fluorescence activated cell sorting analysis of retroviral vector gene transfer into primitive umbilical cord blood cells.
    McCowage GB; Phillips KL; Gentry TL; Hull S; Kurtzberg J; Gilboa E; Smith C
    Exp Hematol; 1998 Apr; 26(4):288-98. PubMed ID: 9546311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. During ontogeny primitive (CD34(+)CD38(-)) hematopoietic cells show altered expression of a subset of genes associated with early cytokine and differentiation responses of their adult counterparts.
    Oh IH; Lau A; Eaves CJ
    Blood; 2000 Dec; 96(13):4160-8. PubMed ID: 11110687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transplantation of human umbilical cord blood cells in macrophage-depleted SCID mice: evidence for accessory cell involvement in expansion of immature CD34+CD38- cells.
    Verstegen MM; van Hennik PB; Terpstra W; van den Bos C; Wielenga JJ; van Rooijen N; Ploemacher RE; Wagemaker G; Wognum AW
    Blood; 1998 Mar; 91(6):1966-76. PubMed ID: 9490679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cocultivation of umbilical cord blood cells with endothelial cells leads to extensive amplification of competent CD34+CD38- cells.
    Rosler E; Brandt J; Chute J; Hoffman R
    Exp Hematol; 2000 Jul; 28(7):841-52. PubMed ID: 10907646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glass needle-mediated microinjection of macromolecules and transgenes into primary human blood stem/progenitor cells.
    Davis BR; Yannariello-Brown J; Prokopishyn NL; Luo Z; Smith MR; Wang J; Carsrud ND; Brown DB
    Blood; 2000 Jan; 95(2):437-44. PubMed ID: 10627447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Growth properties of hematopoietic stem/progenitor cells in the second or third trimester and term fetal cord blood].
    Ma Y; Zou P; Xiao J; Huang S
    Zhonghua Yi Xue Za Zhi; 2002 Mar; 82(5):330-3. PubMed ID: 11953192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of novel circulating human embryonic blood stem cells.
    Gallacher L; Murdoch B; Wu D; Karanu F; Fellows F; Bhatia M
    Blood; 2000 Sep; 96(5):1740-7. PubMed ID: 10961872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stem cell enumeration in cord blood vs bone marrow and peripheral blood.
    Bertolini F; Battaglia M; Lanza A; Gibelli N; Palermo B; Pavesi L; Robustelli della Cuna G
    Bone Marrow Transplant; 1998 Jul; 22 Suppl 1():S57. PubMed ID: 9715890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel protocol that allows short-term stem cell expansion of both committed and pluripotent hematopoietic progenitor cells suitable for clinical use.
    Astori G; Malangone W; Adami V; Risso A; Dorotea L; Falasca E; Marini L; Spizzo R; Bigi L; Sala P; Tonutti E; Biffoni F; Rinaldi C; Del Frate G; Pittino M; Degrassi A
    Blood Cells Mol Dis; 2001; 27(4):715-24; discussion 725-7. PubMed ID: 11778655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-efficiency retroviral transduction of fetal liver CD38-CD34++ cells: implications for in utero and ex utero gene therapy.
    Ohkubo T; Bárcena A; Smith CA; Harrison MR; Muench MO
    Fetal Diagn Ther; 2001; 16(5):299-307. PubMed ID: 11509853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of CD34+HLA-DR-CD38+ and CD34+HLA-DR-CD38- progenitor cells from human umbilical cord blood.
    Cicuttini FM; Welch K; Boyd AW
    Growth Factors; 1994; 10(2):127-34. PubMed ID: 7520715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue source dictates lineage outcome of human fetal CD34(+)CD38(-) cells.
    Poznansky MC; Olszak IT; Foxall RB; Piascik A; Adams GB; Evans RH; Cheng T; Scadden DT
    Exp Hematol; 2001 Jun; 29(6):766-74. PubMed ID: 11378272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MAP kinase activation by mu opioid receptor in cord blood CD34(+)CD38(-) cells.
    Rozenfeld-Granot G; Toren A; Amariglio N; Nagler A; Rosenthal E; Biniaminov M; Brok-Simoni F; Rechavi G
    Exp Hematol; 2002 May; 30(5):473-80. PubMed ID: 12031654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.